Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)

3.20
Delayed Data
As of Apr 20
 -0.0234 / -0.73%
Today’s Change
2.75
Today|||52-Week Range
5.00
-7.34%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-27.6M-48.1M-38.8M-21.1M
 
 
 
 
 
Depreciation36.0K96.0K206.0K64.0K
 
 
 
 
 
Total Other Cash Flow3.7M4.5M3.4M1.8M
 
 
 
 
 
Funds From Operations-23.9M-43.5M-35.2M-19.3M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.0M-987.0K2.1M-135.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-22.8M-42.5M-37.3M-19.1M
 
 
 
 
 
 
InvestingIncrease In Investments0.00-28.6M0.000.00
 
 
Decrease In Investments0.004.7M45.0K7.2M
 
 
 
 
Capital Expenditures-319.0K-118.0K-66.0K-5.0K
 
 
 
 
 
Other Investing - Uses-73.0K0.000.000.00
 
 
Other Investing - Sources0.000.0016.6M0.00
 
 
Net Cash Flow Investing-392.0K-24.2M16.6M7.2M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-280.0K0.000.000.00
 
 
Net Proceeds Stock Sale47.8M47.7M20.5M18.5M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing5.7M0.000.000.00
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing53.2M47.7M20.5M18.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-3.0K-4.0K-11.0K-5.0K
 
 
 
 
 
 
Net Change In Cash30.0M-19.0M-223.0K6.6M